Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Vial
AddedFeb 15, 2024
UpdatedJun 18, 2026
Vial

Vial

Series A

Vial, a CRO, revolutionizes clinical trials for biotech sponsors, offering faster, cost-effective results via tech integration.

HQ
San Francisco, CA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Vial, founded as a contract research organization (CRO), is dedicated to transforming clinical trials for biotech sponsors. The company's core mission is to enable scientists to discover groundbreaking therapeutics that improve human health and happiness. Vial offers a comprehensive suite of services, including trial onboarding, patient enrollment, site communication, and data collection, all integrated into a modern technology platform. The company focuses on various therapeutic areas such as oncology, dermatology, ophthalmology, gastroenterology, CNS, cardiology, respiratory, and rare diseases.

Notable figures affiliated with Vial include experienced professionals in clinical operations and technology integration. The company has attracted significant investment from prominent venture capital firms. Key achievements include the successful execution of numerous clinical trials that have accelerated the development of new therapies while reducing costs. Vial's innovative approach has had a substantial impact on the biotech industry, making clinical trials more efficient and accessible.

Vial - Similar Companies

Clinical Research IO logo

Clinical Research IO

Clinical.Ly logo

Clinical.Ly

clinical.ly

On-Time Trials logo

On-Time Trials

ontimetrials.com

Vitalief logo

Vitalief

vitalief.com

TrialSpark logo

TrialSpark

trialspark.com

Medable logo

Medable

medable.com

ClinOne logo

ClinOne

clinone.com

Curavit Clinical Research logo

Curavit Clinical Research

iClinical logo

iClinical

Jeeva logo

Jeeva

jeevatrials.com

Power Life Science logo

Power Life Science

withpower.com

Endpoint Clinical logo

Endpoint Clinical

Biogenesis Trials logo

Biogenesis Trials

mybiogenesis.com

FindMeCure logo

FindMeCure

findmecure.com

Curebase logo

Curebase

curebase.com

Vial - Quick Facts

Who are Vial's competitors?

Companies similar to Vial include Clinical Research IO, Clinical.Ly, On-Time Trials and Vitalief.

When was Vial founded?

Vial was founded in 2020.

Where is Vial's headquarters located?

Vial's headquarters is located in San Francisco, CA, US.

When was Vial's last funding round?

Vial's most recent funding round was for $34M (USD) in November 2022.

How much has Vial raised to-date?

As of Nov 30, 2022, Vial has raised a total of $101M (USD).

How many employees does Vial have?

Vial has 187 employees as of Feb 4, 2024.

Vial - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
  • Data
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Clinical Trials
Tags
  • Healthtech
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified